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Hyperbaric oxygen: a useful adjunct for purpura fulminans: case
report and review of the literature

Introduction
Purpura Fulminans (PF), also known
as Purpura Gangrenosa, is a fulminant and
devastating disease, usually of children.
Three forms of PF are described:
• Idiopathic Purpura Fulminans
• associated with the post infectious period of a
benign disease, most commonly seen during
recovery from chicken pox or strep
• Acute Infectious Purpura Fulminans
• associated with severe sepsis, usually with
meningococcemia or streptococcemia.
• Neonatal Purpura Fulminans
• due to congenital clotting factor deficiencies.

In PF, clotting factor deficiencies in conjunction with
disseminated intravascular coagulopathy (DIC)
lead to:
• Intravascular occlusion with micro-thrombi and a
hemorrhagic vasculitis.
• Cutaneous and visceral ecchymosis and edema
• Ischemia, gangrene and shock.

Typical lesions:
• symmetrical ecchymoses on the extremities (lower predominate) and buttocks.
• The lesions are painful and progress to necrosis, hemorrhagic blebs and gangrene.

Introduction- M&M
PF has a high mortality rate, variously reported as
13,36,44 or 90%. Significant morbidity occurs in
almost all patients given the high rate of
amputations and invalidity.
• One series (n=70) reported amputations to all
extremities in 25%.
• In another 3/9 died and 5/6 of the survivors had at
least 2 amputations
• Disfiguring facial involvement occurs frequently

Introduction- Treatment
Treatments for this disease include:
• Heparin/low molecular weight Heparin
• fresh frozen plasma
• empiric antibiotics covering MRSA, Neisseria
and streptococcal species
• low molecular weight dextran
• steroids.
• In deficiency states, antithrombin III and protein
C concentrates are given
• Intra-arterial thrombolysis has been utilized as
well as sympathectomy or regional anesthesia to
reduce vasospasm
• Often require fasciotomy for compartment
syndrome and excision of gangrenous areas to
prevent invasive sepsis

Case Report
A previously healthy, 43 year old male with an
apparent flu-like illness precipitously declined the day
following the onset of symptoms. He developed:
• Pneumococcal Sepsis
• Renal Failure With Anuria
• Shock With Brief PEA Arrest
• Disseminated Intravascular Coagulation (DIC)
• Purpura Fulminans (PF)
He required one week of aggressive care before being
stable enough to consider HBOT. He required
continuous renal replacement therapy, antibiotics,
blood products and ventilator support.

Case Report- HBOT
His initial course of HBOT was complicated by
upper airway infection (viral stomatitis) & marked
confusion.
He required intubation for airway control and to
decrease the work of breathing. He tolerated a tpiece better than our simplistic chamber ventilator
(Sechrist 500a).

Case Report- Outcome
• He received 17 HBO treatments in total
• (twice daily at first) done at only 2.0 ATA as we
were unable to give air breaks on T-piece.
• Transcutaneous oximetry was not done but may have
aided in determining an endpoint to HBOT.
• Marked reduction of purpuric, ischemic appearing
tissue with good demarcation of blackened tissue to
the distal digits.

40 days out

Case Report- Outcome
Adjunctive HBOT treatment spared much at
risk tissue.
At one month follow up it was apparent that he
would need some distal amputation of his digits
but, he would have good function of all
proximal joints including thumbs and great
toes.
His renal function was improving- He would not
require long-term dialysis.

Long term: He refused a right foot amputation
and deals with chronic osteomyelitis in that
foot. Otherwise he is high functioning with
family and employment.

Review of Literature
• A Medline search was done using the key words
purpura fulminans and gangrenosa in
conjunction with hyperbaric oxygen.
• Fifteen case report papers were identified, with
only 19 total patients with purpura fulminans
treated with HBOT
• An additional unpublished report was found that
noted six children who did well with early and
aggressive HBOT (Personal communication, P.
Allinson).
• No controlled studies were found to exist.

Hyperbaric oxygen appeared to be of value in most of
the reported cases, and the degree of improvement
appears to be associated with the timeliness as well
as the aggressiveness of the treatments.
Aggressive treatment started within 24 hours- did well
in both short- and long term, with only some minor
distal digital amputations necessary

Those treated late (five- to 10 days post-onset of PF)
had more variable results. Two out of five required
below-the-knee amputation, and another required
multiple debridement and skin grafting. A fourth patient
had minor digit loss.

Discussion
Hyperbaric oxygen appears to ameliorate the
complications of purpura fulminans by:
• reducing edema
• increasing local tissue oxygenation via increased
partial pressures and increased diffusion
distance
• attenuating reperfusion injury and platelet
aggregation
• enhancing leukocyte-killing activity
• capillary and fibroblast proliferation and collagen
production

Discussion
In addition, HBOT may provide benefit by
increasing red blood cell (RBC) deformation,
allowing RBCs to perfuse areas that they otherwise
could not due to capillary and small arteriolar
damage from the purpura fulminans or from
impaired RBC deformability contributing to sludging
and inability to offload oxygen through the capillary
Hyperbaric oxygen appears to be useful in other
purpuric eruptions such as Henoch-Schonlein
purpura and thrombotic thrombocytopenic purpura,
likely by the same mechanisms

Conclusions
1. Multiple reports emphasize the use of early and
aggressive hyperbaric oxygen in purpura fulminans
balancing its utility against issues of hemodynamic
instability and potential pulmonary oxygen toxicity.
2. Transcutaneous oximetry may be useful in
determining an endpoint to treatment with
hyperbaric oxygen.
3. Although a randomized controlled study is fairly
infeasible, a retrospective case-controlled study
comparing cases treated with and without
hyperbaric oxygen may better define the
usefulness of HBO2 for purpura fulminans as well
as clarify the issues of early versus late treatment
and the utility of aggressive therapy.
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